GSK OTC Products Spark Bidding War
The GSK portfolio, which includes products like pain and fever reliever Solpadeine, vitamin and supplements line Abtei, and feminine cleansing product Lactacyd, is also coveted by Bain Capital LLC, Dow Jones Newswires reported Monday, adding that the the portfolio could fetch $3 billion.
Attempts by Law360 to confirm the...
Already a subscriber? Click here to login